CLASS II Device recall · Reported 7 Oct 2020 · FDA Enforcement Report

Uibc; Catalog Number: OSR61205; UDI (01) 15099590011925; IVD; Rx recalled

Beckman Coulter is recalling Uibc; Catalog Number: OSR61205; UDI (01) 15099590011925; IVD; Rx, distributed nationwide in the US. The recall was initiated on 18 Aug 2020 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLOT 2690; Expiration date 10/01/2021
Quantity recalled219 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-3028-2020
FDA event ID
86273
Recalling firm
Beckman Coulter, Brea, CA
Classification
Class II
Status
Terminated
Recall initiated
18 Aug 2020
FDA classified
30 Sep 2020
Reported
7 Oct 2020
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

18 Aug 2020Recall initiated by company
30 Sep 2020Classified by FDA+43 days
7 Oct 2020Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The manufacturer has identified that the use of Unsaturated Iron Binding Capacity (UBIC) lot 2690 will produce erroneously high patient results at the low end of the linear range.

Product as listed by the FDA

UIBC; Catalog Number: OSR61205; UDI (01) 15099590011925; IVD; Rx Only; WARNING H316 H317 H351 H373 H411 - Product Usage: System reagent for the quantitative determination of Unsaturated Iron Binding Capacity (UIBC) in human serum and plasma on Beckman Coulter AU analyzers.

Where it was distributed

Worldwide distribution - US Nationwide distribution including in the states of CA, FL and NJ. The countries of Algeria, Egypt, Philippines and Taiwan.

Nationwide CaliforniaFloridaNew Jersey

Questions about this recall

Why was it recalled?

The manufacturer has identified that the use of Unsaturated Iron Binding Capacity (UBIC) lot 2690 will produce erroneously high patient results at the low end of the linear range.

Which lots are affected?

LOT 2690; Expiration date 10/01/2021

Where was it sold?

Worldwide distribution - US Nationwide distribution including in the states of CA, FL and NJ. The countries of Algeria, Egypt, Philippines and Taiwan.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Beckman Coulter

All 334

Other Test Kits & Diagnostics recalls

All 2,656